Efficiency analysis of multiple sclerosis therapies
At a glance
In this project, various questions regarding the efficacy of approved multiple sclerosis (MS) therapies were analyzed. This included descriptive analyses of various medical metrics, as well as time-to-event models corrected for real-world biases. The analysis is based on the real-world data of NTD.